Vinge is advising the founder and major shareholders in connection with the sale of Dynamic Code AB.
Dynamic Code develops and sells self-sampling kits based on DNA technology. The samples are analysed in Dynamic Code’s own lab and the test results are obtained through a code online. Care and treatment is thereafter offered via digital health care providers and Dynamic Code has, based on that, been able to create a complete chain of health care through its e-health platform.
Closing of the transaction is subject to due diligence and that shareholders representing 95 per cent of all shares in Dynamic Code adhere to the share transfer agreement.
The Vinge team includes Anna Edström, Magnus Hedsund and Niklas Törnell.
